Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Greenland MinesGRML -43.81%12 3-1 Month Momentum % is -50.60% as of Aug. 26, 2026. GuruFocus rates GRML with a GF Score™ of 12/100. Among 2,514 Metals & Mining companies, Greenland Mines ranks worse than 97.45% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-26), Greenland Mines's 3-1 Month Momentum % is -50.60%.
The industry rank for Greenland Mines's 3-1 Month Momentum % or its related term are showing as below:
GRML's 3-1 Month Momentum % is ranked worse than 97.45% of 2514
companies
in the Metals & Mining industry
Industry Median: -16.67
vs GRML: -50.60
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Greenland Mines 3-1 Month Momentum % Related Terms
GRML vs SRGZ, DYNR, RITE: 3-1 Month Momentum % Comparison
For the Other Precious Metals & Mining subindustry, Greenland Mines's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Greenland Mines 3-1 Month Momentum % vs Metals & Mining Industry
For the Metals & Mining industry and Basic Materials sector, Greenland Mines's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Greenland Mines's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Greenland Mines (GRML) has a 3-1 Month Momentum % of -50.60% as of Aug. 26, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Greenland Mines and its competitors. According to the industry distribution chart, Greenland Mines ranks #2450 out of 2514 companies in the Metals & Mining industry, placing it in the top 97.5%.
Is Greenland Mines' 3-1 Month Momentum % too high?
Greenland Mines' current 3-1 Month Momentum % is -50.60%. Based on the distribution chart, Greenland Mines ranks #2450 out of 2514 companies in the Metals & Mining industry, which is in the bottom quartile relative to peers. Overall, Greenland Mines has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Greenland Mines' 3-1 Month Momentum % compare to SRGZ and DYNR?
According to the Metals & Mining industry distribution chart, Greenland Mines ranks #2450 out of 2514 companies for 3-1 Month Momentum %. This places Greenland Mines in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Metals & Mining company?
A good 3-1 Month Momentum % depends on the Metals & Mining industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Greenland Mines and its competitors. Greenland Mines's current 3-1 Month Momentum % is -50.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenland Mines stock overvalued right now?
Greenland Mines (GRML) has a current 3-1 Month Momentum % of -50.60%. The current 3-1 Month Momentum % is -50.60%. Greenland Mines' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Greenland Mines (GRML), the current 3-1 Month Momentum % is -50.60% as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
12GF Score
Get the complete analysis for GRML
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRML has been successfully added to your 
